Share

    


Home / Search Results

Search Results

You searched for:

    Displaying results 1 - 20 of 25
  • 1
  • 2
  • »
Because of the COVID-19 pandemic, Wilmot Cancer Institute's integrative oncology team shares how integrative oncology-based services can be delivered via telehealth.
The COVID-19 pandemic has had a negative impact in the rate of cancer screening across various states in the United States. Louisiana, Delaware, Kentucky and Northern Michigan serve as vehicles for an analysis of the disparity in cancer screening rates, before and after the pandemic.
Due to the COVID-19 pandemic and its associated risks for patients with cancer, all Life with Cancer programming was cancelled on Mar. 12, 2020. Staff, struggling with their own anxiety over personal safety, quickly went into action on how best to continue to meet the psychological and educational needs of patients and families.
The Ohio State University Comprehensive Cancer Center developed the James Cancer Diagnostic Center, to deliver a comprehensive assessment of signs or symptoms of malignancy in a timely fashion.
Despite scientific and medical advances, the incidence and mortality rates of cancer remain disproportionately high among certain populations. Understanding this, combatting the inequities that exist will be key to delivering next generation cancer care.
This Modern Healthcare virtual briefing gathered industry leaders to discuss how digital transformation and health equity will help shape the hospital of the future.
Charleston Area Medical Center Cancer Center is the largest cancer program in Southern West Virginia. The cancer center opened a new treatment clinic to offer pre- and post-treatment visits to better help patients navigate their cancer journey.
Following the disparate outcomes of the COVID-19, combatting the inequities that exist within the American healthcare system remains a key objective of ACCC.
Amid the implementation of technological solutions such as remote patient monitoring in cancer care, it is important that all patients with cancer—regardless of race, ethnicity, and socio-economic status—benefit equitably.
A national survey was conducted to analyze the approach cancer programs adopt toward patient access today, highlighting the current challenges, and operational methods of different cancer care delivery models.
Discover how St. Elizabeth Cancer Center launched a comprehensive program to perform outreach to patients with outstanding orders for lung, breast, and colon cancer screenings.
Disparities in evaluation, management, and mortality persist in patient populations where bladder cancer is less common.
The overall cancer rate among adolescents and young adults is on a gradual increase, thus creating the need for oncology programs geared towards young adults and adolescents.
Highlands Oncology Group took key steps toward implementing an ePRO platform aimed at reducing emergency department utilization and unplanned hospitalization, while improving the patient’s quality of life.
When the COVID-19 public health emergency heightened, everyone’s priorities shifted and the Patient and Family Advisory Council moved to the virtual space.
ACCC and AstraZeneca were recognized for their joint effort in the Rural Appalachian Lung Cancer Screening Initiative at the Cancer Moonshot: Goals Forum hosted, by the President and First Lady.
An interview with Kathyrn Smolinski, MSW, JD on the development and implementation of the medical-legal partnership between Wayne State University Law School and the Karmanos Cancer Institute.
Backed by strategic partnerships, ACCC held a multistakeholder meeting focused on exploring the current state of psychosocial support in oncology.
The interdisciplinary team at Baptist Health, Miami Cancer Institute evaluated existing processes and leveraged technology to improve oral oncolytic compliance through education, consent, and adherence standards.
ACCC conducted a national, institution-directed quality improvement initiative aimed at increasing the rates of guideline-concordant genetic counseling and testing in patients with Stage 0 to III breast cancer, where results could impact care.
    Displaying results 1 - 20 of 25
  • 1
  • 2
  • »